[1] 林兰, 李乾.Cullin7蛋白在原发性肝癌癌组织中的表达及其与临床病理特征的关系[J].新疆医科大学学报, 2019, 42(2):221-225.
[2] 蔡馨, 陈娟娟, 汤冬玲, 等.AFP联合GGT/AST对HBV相关肝细胞癌的诊断价值[J].临床肝胆病杂志, 2021, 37(9):2109-2112.
[3] 唐维, 黄广优, 陈坚贤, 等.根治性肝切除术后抗病毒治疗对HBV相关性肝细胞癌患者预后的影响[J].广西医学, 2018, 40(3):279-283.
[4] BOZIKI M, GRIGORIADIS N.An update on the role of matrix metalloproteinases in the pathogenesis of multiple sclerosis[J].Med Chem, 2018, 14(2):155-169.
[5] CAO S, ZHU S, YIN W, et al.Relevance of EGFR between serum VEGF and MMP-9 in primary hepatocellular carcinoma patients with transarterial chemoembolization[J].Onco Targets Ther, 2020, 13:9407-9417.
[6] PUJADA A, WALTER L, PATEL A, et al.Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer[J].Oncotarget, 2017, 8(55):94650-94665.
[7] WALTER L, CANUP B, PUJADA A, et al.Matrix metalloproteinase 9(MMP9) limits reactive oxygen species (ROS) accumulation and DNA damage in colitis-associated cancer[J].Cell Death Dis, 2020, 11(9):767-780.
[8] 中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].中国实用外科杂志, 2020, 40(2):121-138.
[9] QIU J F, YE J Z, FENG X Z, et al.Pre-and post-operative HBsAg levels may predict recurrence and survival after curative resection in patients with HBV-associated hepatocellular carcinoma[J].J Surg Oncol, 2017, 116(2):140-148.
[10] WALTER L, PUJADA A, BHATNAGAR N, et al.Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis[J].Oncotarget, 2017, 8(1):364-378.
[11] CHEN J, XU W, CHEN Y, et al.Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I Interferon (IFN) receptor 1 to repress IFN/JAK/STAT Signaling[J].J Virol, 2017, 91(8):e01824-1816.
[12] CHUNG T W, MOON S K, LEE Y C, et al.Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells[J].Arch Biochem Biophys, 2002, 408(2):147-154.
[13] ZHANG J, YU H, SUN F Y, et al.Effects of lamivudine on cell proliferation of liver cancer and expressions of HBsAg, HBeAg, and MMP-9 in patients[J].Eur Rev Med Pharmacol Sci, 2019, 23(20):9093-9098.
[14] WU J, GAO W, TANG Q, et al.M2 macrophage-derived exosomes facilitate HCC metastasis by transferring αM β2 integrin to tumor cells[J].Hepatology, 2021, 73(4):1365-1380.
[15] SHIN Y, KIM S, GHATE N, et al.MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis[J].Oncogene, 2022, 41(4):560-570.
[16] LIU LZ, ZHANG Z, ZHENG B H, et al.CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma[J].Hepatology, 2019, 69(1):143-159.
[17] KAMOSHIDA G, OGAWA T, OYANAGI J, et al.Modulation of matrix metalloproteinase-9 secretion from tumor-associated macrophage-like cells by proteolytically processed laminin-332(laminin-5)[J].Clin Exp Metastasis, 2014, 31(3):285-291.
[18] PEGO E R, FERNANDEZ I, NUNEZ M J.Molecular basis of the effect of MMP-9 on the prostate bone metastasis:a review[J].Urol Oncol, 2018, 36(6):272-282.
[19] WANG G, LIU J, CAI Y, et al.Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis[J].Oncotarget, 2017, 8(42):71867-71880.
[20] 刘雪梅, 骆雯, 刘黎.肝细胞癌R0切除术后患者预后与细胞外基质重构相关蛋白和缝隙连接蛋白水平相关性研究[J].中西医结合肝病杂志, 2018, 28(3):145-147, 161.
[21] HUANG H.Matrix metalloproteinase-9(MMP-9) as a cancer biomarker and MMP-9 biosensors:recent advances[J].Sensors(Basel), 2018, 18(10):3249-3267. |